Evaluation of Diabetes Drug Safety
Dr. Buse is also the president-elect for medicine and science of the American Diabetes Association.
A hearing was held on the role of the Food and Drug Administration in evaluating the safety of Avandia, a drug used in the treatment of Type… read more
A hearing was held on the role of the Food and Drug Administration in evaluating the safety of Avandia, a drug used in the treatment of Type 2 diabetes. FDA officials testified about post-marketing surveillance of new drugs and “meta-analysis.” Avandia was approved by the FDA in 1999. Dr. Nissen testified about his study linking Avandia use with a 43 percent increased risk of heart attack. Dr. Buse testified about increased cholesterol in Avandia-using patients. Witnesses emphasized the need for earlier studies and more sensitive protocols. Dr. Slaoui testified about GlaxoSmithKline’s research and actions.
Dr. Buse is also the president-elect for medicine and science of the American Diabetes Association. close
People in this video
More PeopleHosting Organization
Related Video
-
Prescription Drug Safety
Food and Drug Administration Commissioner Andrew C. von Eschenbach talked about efforts to balance drug safety, risk, be…
-
Food and Drug Administration Oversight
Members of the Food and Drug Administration’s Science Board testified about the report, “The FDA Commission at Risk,” th…
-
FDA Oversight
Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional ove…
-
FDA Oversight of Drugs
Dr. Andrew Von Eschenbach talked about the Food and Drug Administration oversight of drugs, the drug approval and inspec…